Kava in the Treatment of Chronic Anxiety
Grant number: 628875 | Funding period: 2010 - 2013
Related publications (26)
S-adenosyl methionine (SAMe) versus escitalopram and placebo in major depression RCT: Efficacy and effects of histamine and carnitine as moderators of response
Jerome Sarris, George I Papakostas, Ottavio Vitolo, Maurizio Fava, David Mischoulon
OBJECTIVE: To assess the antidepressant efficacy of S-adenosyl methionine (SAMe), a naturally occurring methyl donor, versus the s..
Naturopathic medicine for treating self-reported depression and anxiety: An observational pilot study of naturalistic practice
J Sarris, S Gadsden, I Schweitzer
Overview: We conducted the first observational study of a case series of naturopathic consultations of adults who presented with s..
Integrative mental healthcare White Paper: Establishing a new paradigm through research, education, and clinical guidelines
J Sarris, R Glick, R Hoenders, J Duffy, J Lake
Mental illness accounts for about one-third of adult disability globally, reflecting marked societal and personal suffering, and e..
Kava for the Treatment of Generalized Anxiety Disorder RCT: Analysis of Adverse Reactions, Liver Function, Addiction, and Sexual Effects
J Sarris, C Stough, R Teschke, ZT Wahid, CA Bousman, G Murray, KM Savage, P Mouatt, C Ng, I Schweitzer
Presently, little is known about a number issues concerning kava (Piper methysticum), including (i) whether kava has any withdrawa..
Kava in the Treatment of Generalized Anxiety Disorder A Double-Blind, Randomized, Placebo-Controlled Study
Jerome Sarris, Con Stough, Chad A Bousman, Zahra T Wahid, Greg Murray, Rolf Teschke, Karen M Savage, Ashley Dowell, Chee Ng, Isaac Schweitzer
Kava (Piper methysticum) is a plant-based medicine, which has been previously shown to reduce anxiety. To date, however, no placeb..
Pharmacogenetic polymorphisms and response to escitalopram and venlafaxine over 8 weeks in major depression
Chee Ng, Jerome Sarris, Ajeet Singh, Chad Bousman, Keith Byron, Lai Huat Peh, Deidre Joy Smith, Chay Hoon Tan, Isaac Schweitzer
OBJECTIVE: The objective of this study is to investigate the influence of the 5-HTTLPR (serotonin transporter-linked promoter regi..
Plant-Based Medicines for Anxiety Disorders, Part 2: A Review of Clinical Studies with Supporting Preclinical Evidence
Jerome Sarris, Erica McIntyre, David A Camfield
Research in the area of herbal psychopharmacology has revealed a variety of promising medicines that may provide benefit in the tr..
Aripiprazole as augmentation therapy in bipolar patients with current minor or subsyndromal mood symptoms.
Isaac Schweitzer, Jerome Sarris, Virginia Tuckwell, Kay Maguire, Deidre Smith, Chee Ng
BACKGROUND: This study aims to evaluate the effectiveness of aripiprazole augmentation of maintenance treatment for bipolar disord..
Does a Medicinal Dose of Kava Impair Driving? A Randomized, Placebo-Controlled, Double-Blind Study
J Sarris, E Laporte, A Scholey, R King, A Pipingas, I Schweitzer, C Stough
OVERVIEW: Increasing concerns over the potentially impairing effects of prescriptive sedative drugs such as benzodiazepines on dri..
Participant experiences from chronic administration of a multivitamin versus placebo on subjective health and wellbeing: a double-blind qualitative analysis of a randomised controlled trial
Jerome Sarris, Katherine HM Cox, David A Camfield, Andrew Scholey, Con Stough, Erin Fogg, Marni Kras, David J White, Avni Sali, Andrew Pipingas
BACKGROUND: While many randomised controlled trials have been conducted on multivitamins, to our knowledge no qualitative research..
St John's Wort (Hypericum perforatum) versus Sertraline and Placebo in Major Depressive Disorder: Continuation Data from a 26-Week RCT
J Sarris, M Fava, I Schweitzer, D Mischoulon
Hypericum perforatum (St John's wort: SJW) has been extensively studied as an antidepressant in short-term trials, however little ..
The Cognitive-Enhancing Effects of Bacopa monnieri: A Systematic Review of Randomized, Controlled Human Clinical Trials
Matthew P Pase, James Kean, Jerome Sarris, Chris Neale, Andrew B Scholey, Con Stough
OBJECTIVES: Traditional knowledge suggests that Bacopa monnieri enhances cognitive performance. Such traditional beliefs have now ..
Complementary medicine, self-help, and lifestyle interventions for Obsessive Compulsive Disorder (OCD) and the OCD spectrum: A systematic review
Jerome Sarris, David Camfield, Michael Berk
BACKGROUND: In Obsessive Compulsive Disorder (OCD) current standard pharmacotherapies may be of limited efficacy. Non-conventional..
Complementary Medicine, Exercise, Meditation, Diet, and Lifestyle Modification for Anxiety Disorders: A Review of Current Evidence
J Sarris, S Moylan, DA Camfield, MP Pase, D Mischoulon, M Berk, FN Jacka, I Schweitzer
Use of complementary medicines and therapies (CAM) and modification of lifestyle factors such as physical activity, exercise, and ..
Herbal medicine for depression, anxiety and insomnia: A review of psychopharmacology and clinical evidence
Jerome Sarris, Alexander Panossian, Isaac Schweitzer, Con Stough, Andrew Scholey
Research in the area of herbal psychopharmacology has increased markedly over the past decades. To date however, a comprehensive r..
Adjunctive nutraceuticals with standard pharmacotherapies in bipolar disorder: a systematic review of clinical trials
Jerome Sarris, David Mischoulon, Isaac Schweitzer
OBJECTIVE: Studies using augmentation of pharmacotherapies with nutraceuticals in bipolar disorder (BD) have been conducted and ..
Nutraceuticals in the treatment of Obsessive Compulsive Disorder (OCD): A review of mechanistic and clinical evidence
David A Camfield, Jerome Sarris, Michael Berk
Obsessive-compulsive disorder (OCD) is a debilitating mental illness which has a significant impact on quality of life. First-line..